Stabilization of proteins against methylene chloride/water interface-induced denaturation and aggregation

Journal of Controlled Release

Volumn 58, Issue 2, 1999, Pages 143-151

  Sah, Hongkee ^a  

^a Room 214 26 S Dunlap St Dept P ^*  (United States)

Author keywords

Adsorption; Microencapsulation; Protein stability; W O interface

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; BOVINE SERUM ALBUMIN; DICHLOROMETHANE; LYSOZYME; MICROSPHERE; ORGANIC SOLVENT; OVALBUMIN; WATER;

ADSORPTION; ARTICLE; EMULSION; MICROENCAPSULATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DENATURATION; PROTEIN STABILITY;

EID: 0033039914     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(98)00148-5     Document Type: Article

References (25)

1. Watts P.J., Davies M.C., Melia C.D. Microencapsulation using emulsification/solvent evaporation: an overview of techniques and applications. CRC Crit. Rev. Ther. Drug Carrier Syst. 7:1990;235-259.
2. J.P. Benoit, H. Marchais, H. Rolland, V.V. Velde, Biodegradable microspheres: advances in production technology, in: S. Benita (Ed.), Microencapsulation: Methods and Industrial Applications, Marcel Dekker, New York, 1996, pp. 35-72.
3. Sah H., Toddywala R., Chien Y.W. Continuous release of proteins from biodegradable microcapsules and in vivo evaluation of their potential as vaccine adjuvant. J. Control. Release. 35:1995;137-144.
4. Singh M., Singh O., Talwar G.P. Biodegradable delivery system for a birth control vaccine: immunogenicity studies in rats and monkeys. Pharm. Res. 12:1995;1796-1800.
5. Morlock M., Knoll H., Winter G., Kissel T. Microencapsulation of rh-erythropoietin, using biodegradable poly(D,L-lactide-co-glycolide): protein stability and the effects of stabilizing excipients. Eur. J. Pharm. Biopharm. 43:1997;29-36.
6. Cleland J.L., Jones A.J.S. Stable formulations of recombinant human growth hormone and interferon-γ for microencapsulation in biodegradable microspheres. Pharm. Res. 13:1996;1464-1474.
7. Chen L., Apte R.N., Cohen S. Characterization of PLGA microspheres for the controlled delivery of IL-1α for tumor immunotherapy. J. Control. Release. 43:1997;261-272.
8. Cleland J.L., Lim A., Barrön L., Duenas E.T., Powell M.F. Development of a single- shot subunit vaccine for HIV-1: Part 4. Optimizing microencapsulation and pulsatile release of MN rgp 120 from biodegradable microspheres. J. Control. Release. 47:1997;135-150.
9. Kersten G.F.A., Donders D., Akkermans A., Beuvery E.C. Single shot with tetanus toxoid in biodegradable microspheres protects mice despite acid-induced denaturation of the antigen. Vaccine. 14:1996;1627-1632.
10. Alonso M.J., Gupta R.K., Siber G.R., Langer R. Biodegradable microspheres as controlled release tetanus toxoid delivery systems. Vaccine. 12:1994;299-306.
11. H. Sah, Protein instability toward organic solvent/water emulsification: implications for protein microencapsulation into microspheres. PDA J. Pharm. Sci. Technol. (in press).
12. Liedekerke B.M.V., Nelis H.J., Kint J.A., Vanneste F.W., De Leenheer A.P. Quality control of albumin solutions by size-exclusion high-performance liquid chromatography, isoelectric focusing, and two-dimensional immunoelectrophoresis. J. Pharm. Sci. 80:1991;11-16.
13. Lee J.K., Deluccia F.J., Kelly E.L., Davidson C., Borger F.R. Determination of the molecular size distribution of immunoglobulin G (IgG) in intravenous IgG-albumin formulations by high-performance liquid chromatography. J. Chromatogr. 444:1988;141-152.
14. Liu W.R., Langer R., Klibanov A.M. Moisture-induced aggregation of lyophilized proteins in the solid state. Biotechnol. Bioeng. 37:1991;177-184.
15. Kelly S.T., Zydney A.L. Effect of thiol-disulfide interchange reactions on albumin fouling during membrane microfiltration. Biotechnol. Bioeng. 44:1994;972-982.
16. Jordan G.M., Yoshioka S., Terao T. The aggregation of bovine serum albumin in solution and in the solid state. J. Pharm. Pharmacol. 46:1994;182-185.
17. DePaolis A.M., Advanti J.V., Shrama B.G. Characterization of erythropoietin dimerization. J. Pharm. Sci. 84:1995;1280-1284.
18. Gilbert H.F. Molecular and cellular aspects of thiol-disulfide exchange. Adv. Enzymol. 63:1990;69-172.
19. Peters T. Serum albumin. Adv. Protein Chem. 37:1985;161-245.
20. Lee J.C., Timasheff S.N. The stabilization of proteins by sucrose. J. Biol. Chem. 256:1981;7193-7201.
21. S.N. Timasheff, Stabilization of protein structure by solvent additives, in: T.J. Ahern, M.C. Manning (Eds.), Stability of Protein Pharmaceuticals. Part B. In Vivo Pathways of Degradation and Strategies for Protein Stabilization, Plenum Press, New York, 1992, pp. 265-285.
22. Klotz I.M. Comparison of molecular structures of proteins: helix content; distribution of apolar residues. Arch. Biochem. Biophys. 138:1970;704-706.
23. Matsuyama K., El-Gizway S., Perrin J.H. Thermodynamics of binding of aromatic amino acids to α-, β-, and γ-cyclodextrins. Drug Dev. Ind. Pharm. 13:1987;2687-2691.
24. Haeberlin B., Gengenbacher T., Meinzer A., Fricker G. Cyclodextrins - useful excipients for oral peptide administration? Int. J. Pharm. 137:1996;103-110.
25. Charman S.A., Mason K.L., Charman W.N. Techniques for assessing the effects of pharmaceutical excipients on the aggregation of porcine growth hormone. Pharm. Res. 10:1993;954-962.